Skip to main content

Table 4 Specific treatment of pandemic and postpandemic patients during their stay in ICU

From: ICU-treated influenza A(H1N1) pdm09 infections more severe post pandemic than during 2009 pandemic: a retrospective analysis

Variables 2009–2010
Pandemic (n = 16)
2012–2016
Postpandemic (n = 60)
p value
Invasive ventilation 8 (50) 37 (61.7) 0.40
Noninvasive ventilation 9 (56) 42 (70) 0.37
Vasopressor treatment 5 (31) 38 (63.3) 0.03
Renal replacement therapy 1 (6.3) 11 (18.3) 0.44
Duration of invasive ventilation, hours 36.7 (17.5–176.5) 114 (24–193.5) 0.43
Duration of noninvasive ventilation, hours 16 (15–42) 27.7 (7.8–53.6) 0.45
ECMO 0 4 (6.7) 0.57
SOFA circulation    0.042
 0 points 3 (18.8) 3 (5.0)  
 1 point 8 (50.0) 19 (31.7)  
 2 points 0 0  
 3 points 1 (6.3) 16 (26.7)  
 4 points 4 (25.0) 22 (36.7)  
SOFA respiratory    0.38
 0 points 1 (6.3) 1 (1.7)  
 1 point 1 (6.3) 7 (11.7)  
 2 points 6 (37.5) 12 (20.0)  
 3 points 3 (18.8) 16 (26.7)  
 4 points 5 (31.3) 24 (40.0)  
  1. ECMO extracorporeal membrane oxygenation, ICU intensive care unit, SOFA Sequential Organ Failure Assessment
  2. Values are presented as median (25th–75th percentile) or as number (percentage) of patients